Literature DB >> 9375674

Uptake of agmatine into rat brain synaptosomes: possible role of cation channels.

M Sastre1, S Regunathan, D J Reis.   

Abstract

Agmatine (decarboxylated arginine), an endogenous ligand for imidazoline receptors, has been identified in brain where it is synthesized from arginine by arginine decarboxylase. Here we report a mechanism for the transport of agmatine into rat brain synaptosomes. The uptake of agmatine was energy- and temperature-dependent and saturable with a Km of 18.83 +/- 3.31 mM and a Vmax of 4.78 +/- 0.67 nmol/mg of protein/min. Treatment with ouabain (Na+,K+-ATPase inhibitor) or removal of extracellular Na+ did not attenuate the uptake rate. Agmatine transport was not inhibited by amino acids, polyamines, or monoamines, indicating that the uptake is not mediated by any amino acid, polyamine, or monoamine carriers. When we examined the effects of some ion-channel agents on agmatine uptake, only Ca2+-channel blockers inhibited the uptake, whereas a reduction in extracellular Ca2+ increased it. In addition, some imidazoline drugs, such as idazoxan and phentolamine, were strong noncompetitive inhibitors of agmatine uptake. Thus, a selective, Na+-independent uptake system for agmatine exists in brain and may be important in regulating the extracellular concentration of agmatine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375674     DOI: 10.1046/j.1471-4159.1997.69062421.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Potential relevance of agmatine as a virulence factor of Helicobacter pylori.

Authors:  G J Molderings; M Burian; J Homann; M Nilius; M Göthert
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

3.  Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons.

Authors:  M-Y Zhu; W-P Wang; G Bissette
Journal:  Neuroscience       Date:  2006-06-13       Impact factor: 3.590

4.  Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury.

Authors:  C A Fairbanks; K L Schreiber; K L Brewer; C G Yu; L S Stone; K F Kitto; H O Nguyen; B M Grocholski; D W Shoeman; L J Kehl; S Regunathan; D J Reis; R P Yezierski; G L Wilcox
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

5.  Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation.

Authors:  G J Molderings; S Menzel; M Kathmann; E Schlicker; M Göthert
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

6.  Effect of agmatine on locus coeruleus neuron activity: possible involvement of nitric oxide.

Authors:  Eduardo Ruiz-Durántez; José A Ruiz-Ortega; Joseba Pineda; Luisa Ugedo
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

7.  Cardiovascular effects of agmatine within the rostral ventrolateral medulla are similar to those of clonidine in anesthetized rats.

Authors:  Jun Yang; Wei-Zhong Wang; Fu-Ming Shen; Ding-Feng Su
Journal:  Exp Brain Res       Date:  2004-10-05       Impact factor: 1.972

Review 8.  Agmatine : metabolic pathway and spectrum of activity in brain.

Authors:  Angelos Halaris; John Plietz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons.

Authors:  Wei-Ping Wang; Abiye H Iyo; Javier Miguel-Hidalgo; Soundar Regunathan; Meng-Yang Zhu
Journal:  Brain Res       Date:  2006-03-20       Impact factor: 3.252

10.  Immunoneutralization of agmatine sensitizes mice to micro-opioid receptor tolerance.

Authors:  Carrie L Wade; Lori L Eskridge; H Oanh X Nguyen; Kelley F Kitto; Laura S Stone; George Wilcox; Carolyn A Fairbanks
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.